5PSQ-080 Effectiveness and security of alemtuzumab in relapsing-remitting multiple sclerosis

BACKGROUND: Alemtuzumab is a humanised monoclonal antibody that selectively targets CD52, resulting in depletion and subsequent distinct repopulation of circulating T and B lymphocytes. PURPOSE: To evaluate the effectiveness and security of alemtuzumab in patients diagnosed with relapsing-remitting...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur J Hosp Pharm
Egile Nagusiak: Lorenzo, M Gutiérrez, Lara, MJ Morales, Alarcón, A Linares, Castillo, I Muñoz
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Group 2018
Gaiak:
Section 5: Patient safety and quality assurance
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535589/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.434
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak